134 related articles for article (PubMed ID: 34642066)
21. Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas.
Ohnleiter T; Antoni D; Lefebvre F; Truntzer P; Schultz P; Burgy M; Borel C; Noël G
Chin Clin Oncol; 2018 Dec; 7(6):60. PubMed ID: 30180748
[TBL] [Abstract][Full Text] [Related]
22. Patterns of failure after postoperative intensity-modulated radiotherapy for locally advanced and recurrent head and neck cancer.
Ooishi M; Motegi A; Kawashima M; Arahira S; Zenda S; Nakamura N; Ariji T; Tokumaru S; Sakuraba M; Tahara M; Hayashi R; Akimoto T
Jpn J Clin Oncol; 2016 Oct; 46(10):919-927. PubMed ID: 27511989
[TBL] [Abstract][Full Text] [Related]
23. Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment.
Moretto F; Rampino M; Munoz F; Ruo Redda MG; Reali A; Balcet V; Badellino S; Piva C; Schena M; Airoldi M; Ostellino O; Pecorari G; Ragona R; Ricardi U
Radiol Med; 2014 Aug; 119(8):634-41. PubMed ID: 24424659
[TBL] [Abstract][Full Text] [Related]
24. Phase II/III Randomized Controlled Trial of Concomitant Hyperfractionated Radiotherapy plus Cetuximab (Anti-EGFR Antibody) or Chemotherapy in Locally Advanced Head and Neck Cancer.
Al-Saleh K; El-Sherify M; Safwat R; Elbasmy A; Shete J; Hussein A; Nazeeh M; Bedair A
Gulf J Oncolog; 2019 May; 1(30):6-12. PubMed ID: 31242976
[TBL] [Abstract][Full Text] [Related]
25. Intensity-modulated radiation therapy with concurrent carboplatin and paclitaxel for locally advanced head and neck cancer: toxicities and efficacy.
Vlacich G; Diaz R; Thorpe SW; Murphy BA; Kirby W; Sinard RJ; Shakhtour B; Shyr Y; Murphy P; Netterville JL; Yarbrough WG; Cmelak AJ
Oncologist; 2012; 17(5):673-81. PubMed ID: 22550060
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of patients with esophageal and gastric cancer in Sri Lanka: A retrospective survival analysis.
Wijesekera S; Alagiyawanna L; Peiris V; Silva DC; Rupasinghe T; Balawardena J; Skandarajah T; Jeyakumaran N; Gunasekera D; Bandusena M; Joseph N
J Cancer Res Ther; 2023 Apr; 19(Supplement):S294-S299. PubMed ID: 37148006
[TBL] [Abstract][Full Text] [Related]
27. Intensity-modulated radiotherapy is associated with improved global quality of life among long-term survivors of head-and-neck cancer.
Chen AM; Farwell DG; Luu Q; Vazquez EG; Lau DH; Purdy JA
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):170-5. PubMed ID: 22300572
[TBL] [Abstract][Full Text] [Related]
28. pN status predicts outcomes in surgically treated pT1-pT2 patients of various disease stages with squamous cell carcinoma of the head and neck: a 17-year retrospective single center cohort study.
Qian X; Sinikovic B; Schreiber F; Ochsenreither S; Klinghammer K; Wollenberg B; Kaufmann AM; Albers AE
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2787-2795. PubMed ID: 30159726
[TBL] [Abstract][Full Text] [Related]
29. Randomized controlled study comparing simultaneous modulated accelerated radiotherapy versus simultaneous integrated boost intensity modulated radiotherapy in the treatment of locally advanced head and neck cancer.
Tandon S; Gairola M; Ahlawat P; Rawat S; Aggarwal A; Sharma K; Tiwari S; Karimi AM; Muttagi V; Sachdeva N; Bhushan M
J Egypt Natl Canc Inst; 2018 Sep; 30(3):107-115. PubMed ID: 29960876
[TBL] [Abstract][Full Text] [Related]
30. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
31. IMRT/VMAT for malignancies in the head-and-neck region : Outcome in patients aged 80.
Brown ML; Glanzmann C; Huber G; Bredell M; Rordorf T; Studer G
Strahlenther Onkol; 2016 Aug; 192(8):526-36. PubMed ID: 27306747
[TBL] [Abstract][Full Text] [Related]
32. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial.
Gupta T; Agarwal J; Jain S; Phurailatpam R; Kannan S; Ghosh-Laskar S; Murthy V; Budrukkar A; Dinshaw K; Prabhash K; Chaturvedi P; D'Cruz A
Radiother Oncol; 2012 Sep; 104(3):343-8. PubMed ID: 22853852
[TBL] [Abstract][Full Text] [Related]
33. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
34. Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial.
Gupta T; Sinha S; Ghosh-Laskar S; Budrukkar A; Mummudi N; Swain M; Phurailatpam R; Prabhash K; Agarwal JP
Radiat Oncol; 2020 Sep; 15(1):218. PubMed ID: 32938468
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning.
Chen AM; Daly ME; Cui J; Mathai M; Benedict S; Purdy JA
Head Neck; 2014 Nov; 36(11):1541-6. PubMed ID: 23996502
[TBL] [Abstract][Full Text] [Related]
36. A Multicentre UK Study of Outcomes for Locally Advanced Sinonasal Squamous Cell Carcinoma Treated with Adjuvant or Definitive Intensity-modulated Radiotherapy.
Slevin F; Pan S; Mistry H; Denholm M; Shor D; Oong Z; Price J; Jadon R; Fleming JC; Barnett G; Dixon L; Prestwich R; Thomson D
Clin Oncol (R Coll Radiol); 2021 Oct; 33(10):e450-e461. PubMed ID: 34147323
[TBL] [Abstract][Full Text] [Related]
37. The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy.
Dietl B; Marienhagen J; Schäfer C; Kölbl O
Clin Oncol (R Coll Radiol); 2007 May; 19(4):228-33. PubMed ID: 17433968
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer.
Sher DJ; Haddad RI; Norris CM; Posner MR; Wirth LJ; Goguen LA; Annino D; Balboni T; Allen A; Tishler RB
Cancer; 2010 Oct; 116(20):4761-8. PubMed ID: 20572036
[TBL] [Abstract][Full Text] [Related]
40. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL
Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]